MYC Point Mutations in Cancer: A Reboot and a Sequel

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MYC point mutations are less explored than other MYC alterations like translocations and amplifications.
• First identified over 40 years ago in lymphoid cancers, research on MYC point mutations remained limited until recent high-throughput sequencing studies.
• Information on MYC point mutations is fragmented across literature and databases, necessitating a systematic compilation.

Purpose of the Study:

• To provide a comprehensive review of MYC point mutations in cancer.
• To illustrate recurrent MYC variants in coding, non-coding, and regulatory regions.
• To identify knowledge gaps and stimulate further research for translational potential.

Main Methods:

• Literature review of MYC point mutations in cancer.
• Analysis of high-throughput sequencing data.
• Systematic collection and description of MYC genetic alterations.

Main Results:

• MYC point mutations occur across various cancer types.
• Recurrent variants are identified in MYC coding, non-coding, and regulatory regions.
• Significant gaps in understanding the functional impact and clinical relevance of these mutations exist.

Conclusions:

• A systematic approach to MYC point mutation research is crucial.
• Further investigation is needed to elucidate the role of MYC point mutations in cancer.
• Addressing knowledge gaps can unlock the translational potential of targeting MYC mutations.